Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abatement, absence, ACS, agility, aid, Alberta, allergic, ally, Andrew, Anixa, anthim, anthrax, antitoxin, antitumor, Antiviral, AppTec, array, ASPR, assembled, Assembly, assignee, Asst, atezolizumab, BARDA, batch, beta, Bexar, biodefense, bioinformatic, biosecurity, bioterrorism, biotherapeutic, biowarfare, Blackhawk, blockade, bowel, brake, bulk, CAGR, Canadian, carryforward, Cassel, CDMO, cemiplimab, CLIN, Cohen, collateralized, combinatorial, Combing, conclusion, constant, construct, constructing, construction, convey, Countering, county, customizable, David, de, decommissioned, defective, denial, denominated, deployment, Deputy, diabetic, dissociation, diversify, DoD, dynamic, earmarked, ecosystem, edema, edge, eighty, elevated, enzymatic, equilibrium, EU, EUND, evidenced, exotoxin, fastest, fatality, FCPA, follicular, foot, footnote, formation, formatted, fuel, garnered, GDPR, Genetech, George, Gregor, Guide, haplotype, harnessing, helper, hematopoietic, heterogeneity, hoc, hope, HotSpot, Ice, ID, idea, iHealthcareAnalyst, immunomodulatory, immunostimulatory, immunosuppression, immunosuppressive, implicit, inappropriate, incorrectly, inflammation, inflammatory, Inline, insurrection, intracellular, inventory, Jack, Kd, Keystone, Kingdom, Kingston, Koblentz, largest, Lasseter, lethal, LIBTAYO, liter, literature, Mark, Mason, MD, MDR, Merchant, merge, movement, multivalent, NaN, nay, Neutralization, neutralizing, nM, NMTC, nonprofit, Nuclear, obiltoxaximab, occupy, om, orphan, outsourced, overstated, PA, Page, partly, Pennsylvania, Perelman, PhD, plant, plasma, plasticity, play, Pocket, Poor, predominantly, premium, presence, programmable, prompted, Pryor, pts, quantity, quickly, Raleigh, RapidVax, raxibacumab, real, reconciled, redistribute, Regeneron, reinforce, Reorganization, repository, resistant, retinopathy, revealed, rheumatoid, Roger, Russian, Salpeter, Secretariat, Senate, Senator, serial, SFL, Shapiro, shortage, slot, slotting, SNS, sped, SSIP, stem, stimulatory, stockpile, stockpiled, stockpiling, strict, subordinate, tabular, TECENTRIQ, tenant, text, ThermoFisher, thought, threat, threatening, toxin, Treg, UK, Ukraine, unamortized, undergoing, undiscounted, unprogrammed, untreated, Unveiled, uptake, usage, waiver, warfare, water, weapon, Webber, wet, whichever, workforce, write, WuXi
Removed:
activated, adaptive, adequacy, Aduro, alongside, Ann, antigenic, applying, attest, begun, BioMedica, boost, breached, chart, combine, complexed, cured, Custom, dermal, die, discovering, dramatically, elicit, enhancing, epitope, exceeding, exhaustion, extracting, Ferry, golden, handful, hourly, HS, humanization, ImmunoCellular, inconvenience, instrumental, intradermal, invasive, isolation, Jumpstart, kill, Korn, led, lifetime, main, mainstay, malignant, managerial, mapping, maturation, matured, men, month, murine, NewLink, observation, obsolete, overcome, Oxford, Oxley, precursor, premier, principle, progressing, PTX, rata, reactive, Robert, robust, Rosar, sequence, show, simplifying, suggest, suppression, surgical, synergistic, systemically, TCAP, tolerate, traditional, transformation, transporting, upregulation, Walkersville, women
Filing tables
Filing exhibits
SCPXD similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
Heat Biologics, Inc.
Morrisville, North Carolina
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-224039 and No. 333-234105), Form S-3 (No. 333-214868, No. 333-237808, No. 333-251255, No. 333-251256 , and No. 333-257051) and Form S-8 (No. 333-193453, No. 333-196763, No. 333-207108, No. 333-213133, No. 333-219238, No. 333-227699, No. 333-233352, No. 333-237137, No. 333-249466, and No. 333-260120) of Heat Biologics, Inc. of our report dated March 25, 2021, relating to the consolidated financial statements which appears in this Form 10-K.
/s/ BDO USA, LLP
BDO USA, LLP
Raleigh, NC
March 11, 2022